HomeInsightsStock Comparison

Kms Medisurgi Ltd vs Shalby Ltd Stock Comparison

Kms Medisurgi Ltd vs Shalby Ltd Stock Comparison

Last Updated on: Jul 04, 2025

Key Highlights

  • The Latest Trading Price of KMS Medisurgi Ltd is ₹ 125.5 as of 04 Jul 16:01.
  • The P/E Ratio of KMS Medisurgi Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Shalby Ltd changed from 18.2 on March 2020 to 30.6 on March 2024 . This represents a CAGR of 10.95% over 5 years.
  • The Market Cap of KMS Medisurgi Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Shalby Ltd changed from ₹ 500.09 crore on March 2020 to ₹ 2584 crore on March 2024 . This represents a CAGR of 38.89% over 5 years.
  • The revenue of KMS Medisurgi Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shalby Ltd for the Mar '25 is ₹ 270.21 crore as compare to the Dec '24 revenue of ₹ 281.05 crore. This represent the decline of -3.86%.
  • The ebitda of KMS Medisurgi Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shalby Ltd for the Mar '25 is ₹ 26.16 crore as compare to the Dec '24 ebitda of ₹ 39.33 crore. This represent the decline of -33.49%.
  • The net profit of KMS Medisurgi Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Shalby Ltd changed from ₹ 20.82 crore to ₹ -12.19 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of KMS Medisurgi Ltd changed from 15 % on March 2020 to 3.67 % on March 2024 . This represents a CAGR of -24.54% over 5 yearsThe Dividend Payout of Shalby Ltd changed from 19.31 % on March 2020 to 12.41 % on March 2024 . This represents a CAGR of -8.46% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About KMS Medisurgi Ltd

  • KMS Medisurgi Limited was incorporated as 'KMS Medisurgi Private Limited' on March 25, 1999 at Mumbai.
  • The Company converted into a Public Limited Company and name was changed to 'KMS Medisurgi Limited' on June 15, 2016. The Company manufactures & undertake job work of coating of various substrates like non woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive.
  • It is engaged in the business of ethical marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipments, Surgery Equipments, Orthopedic/Physiotherapy Equipments, Blood Banking Equipments and other such Surgical Equipments in India. The Company was established in 1999 as surgical equipment company and since then it has been launching new concepts which helped the Indian Healthcare industry.

About Shalby Ltd

  • Shalby Limited was originally incorporated as a Private Limited Company with the name 'Shalby Hospital Private Limited' on August 30, 2004.
  • Subsequently, the Company was converted to a Public Limited Company and the name was changed to 'Shalby Hospital Public Limited' on May 15, 2006.
  • Further, the name of the Company was changed to Shalby Hospitals Limited on July 26, 2006 and then, again changed to Shalby Limited on February 13, 2008. Shalby Limited is an Ahmedabad-headquartered and one of the leading multi-specialty chain of hospitals in India and provides high-quality and economical healthcare services.
  • The Hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

KMS Medisurgi Ltd News Hub

News

KMS Medisurgi to conduct board meeting

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 27 June 2025...

Read more

20 Jun 2025 13:39

News

KMS Medisurgi to table results

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 30 May 2025....

Read more

24 May 2025 13:48

News

KMS Medisurgi to hold board meeting

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

12 Nov 2024 14:12

News

Board of KMS Medisurgi recommends final dividend

KMS Medisurgi announced that the Board of Directors of the Company at its meeting held on ...

Read more

28 Aug 2024 17:43

News

KMS Medisurgi to hold AGM

KMS Medisurgi announced that the 26th Annual General Meeting (AGM) of the company will be ...

Read more

28 Aug 2024 17:43

News

KMS Medisurgi to consider Dividend

KMS Medisurgi will hold a meeting of the Board of Directors of the Company on 28 August 20...

Read more

20 Aug 2024 16:27

Shalby Ltd News Hub

News

Shalby does not recommend dividend

The Board of Shalby at the meeting held on 29 May 2025, has decided not declare the divide...

Read more

29 May 2025 11:32

News

Shalby to conduct board meeting

Shalby will hold a meeting of the Board of Directors of the Company on 29 May 2025. Powere...

Read more

21 May 2025 18:40

News

Shalby slides after reporting net loss of Rs 2 cr in Q3

However, revenue from operations jumped 27.6% YoY to Rs 275.63 crore in the quarter ended ...

Read more

04 Feb 2025 12:11

News

Shalby to convene board meeting

Shalby will hold a meeting of the Board of Directors of the Company on 3 February 2025. Po...

Read more

28 Jan 2025 15:22

News

Shalby gains on USFDA clearance for knee replacement device

Duraniom is the company's primary total knee replacement device with TiNbN coating. Based ...

Read more

16 Jan 2025 11:13

News

Shalby slides after Q2 PAT tumbles 88% YoY to Rs 3 cr

Profit before tax (PBT) stood at Rs 13.70 crore in Q2 FY25, up 67.86% YoY and down 54.95% ...

Read more

30 Oct 2024 17:14

SWOT Analysis Of KMS Medisurgi Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Shalby Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for KMS Medisurgi Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Shalby Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of KMS Medisurgi Ltd and Shalby Ltd

Which company has a larger market capitalization, KMS Medisurgi Ltd or Shalby Ltd?

Market cap of KMS Medisurgi Ltd is 41 Cr while Market cap of Shalby Ltd is 2,008 Cr

What are the key factors driving the stock performance of KMS Medisurgi Ltd and Shalby Ltd?

The stock performance of KMS Medisurgi Ltd and Shalby Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for KMS Medisurgi Ltd and Shalby Ltd?

As of July 4, 2025, the KMS Medisurgi Ltd stock price is INR ₹126.9. On the other hand, Shalby Ltd stock price is INR ₹186.0.

How do dividend payouts of KMS Medisurgi Ltd and Shalby Ltd compare?

To compare the dividend payouts of KMS Medisurgi Ltd and Shalby Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions